|
ZUG, Switzerland, Nov. 18, 2020 /PRNewswire/ -- Pharvaris, a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor... Read more ›› |
By: PR Newswire Association LLC. - 18 Nov 2020
|
Related companies:
Pharvaris GmbH |
|
|
Read more ›› |
By: GlobenewsWire - 18 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 18 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 17 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 16 Nov 2020
|
Related companies:
CRISPR Therapeutics AG |
|
|
Read more ›› |
By: GlobenewsWire - 16 Nov 2020
|
|
|
NEW YORK and BASEL, Switzerland, Nov. 16, 2020 /PRNewswire/ -- Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene therapies for the treatment of rare diseases, today announced that the European Medicines Agency (EMA) has granted orphan... Read more ›› |
By: PR Newswire Association LLC. - 16 Nov 2020
|
Related companies:
Aruvant Sciences, Inc. |
|
|
Project Lucy Submits Pre-IND Briefing Package to the FDA; Agrees Q1 Interim Analysis of Swiss Phase 2a Trial of LSD Assisted Therapy for Anxiety Disorders Read more ›› |
By: PR Newswire Association LLC. - 16 Nov 2020
|
Related companies:
Brain Mind Institute (BMI) |
|
|
Read more ›› |
By: GlobenewsWire - 16 Nov 2020
|
Related companies:
F. Hoffmann-La Roche AG (Venture Fund) |
Hoffmann-La Roche Limited (Roche Canada) |
F. Hoffmann-La Roche AG |
Hoffmann-La Roche Ltd. (Edmonton) |
|
|
Read more ›› |
By: GlobenewsWire - 16 Nov 2020
|
Related companies:
ObsEva SA |
|
|
SHANGHAI, Nov. 16, 2020 /PRNewswire/ -- Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development and manufacturing of a protein-based S-Trimer subunit vaccine candidate. With promising preliminary... Read more ›› |
By: PR Newswire Association LLC. - 16 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 14 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 13 Nov 2020
|
Related companies:
F. Hoffmann-La Roche AG (Venture Fund) |
Hoffmann-La Roche Limited (Roche Canada) |
F. Hoffmann-La Roche AG |
Hoffmann-La Roche Ltd. (Edmonton) |
|
|
Read more ›› |
By: GlobenewsWire - 13 Nov 2020
|
Related companies:
F. Hoffmann-La Roche AG (Venture Fund) |
Hoffmann-La Roche Limited (Roche Canada) |
F. Hoffmann-La Roche AG |
Hoffmann-La Roche Ltd. (Edmonton) |
|
|
ZUG, Switzerland, Nov. 13, 2020 /PRNewswire/ -- Pharvaris, a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor... Read more ›› |
By: PR Newswire Association LLC. - 13 Nov 2020
|
Related companies:
Pharvaris GmbH |
|
|
VEVEY, Switzerland, Nov. 13, 2020 /PRNewswire/ -- On November 13(th), 2020, AlpVision is launching the "AlpVision COVID-19 Initiative" helping pharmaceutical companies to protect COVID-19 relevant medicines against counterfeiting. Read more ›› |
By: PR Newswire Association LLC. - 13 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 13 Nov 2020
|
Related companies:
ObsEva SA |
|
|
CHICAGO, BASEL, Switzerland and NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Roivant Sciences today named EVERSANA(TM), the pioneer of next-generation... Read more ›› |
By: PR Newswire Association LLC. - 12 Nov 2020
|
|
|
ZUG, Switzerland, Nov. 12, 2020 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform to deliver innovative, safe, and broadly accessible treatments to patients with potentially life-threatening conditions,... Read more ›› |
By: PR Newswire Association LLC. - 12 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 12 Nov 2020
|
Related companies:
Sequana Medical NV |
Sequana Medical NV |
|
|
|